Global Team. World-Class Results.
Our mission is to improve patient access to medical care through evidence, worldwide
Pharmerit was founded in 2000 in Rotterdam, NL, to foster creative collaboration among researchers dedicated to uncovering and communicating the value of healthcare innovations. This spirit continued to drive us as we expanded our presence across the United States, Europe, and Asia. Through this time, we have benefited from a consistent vision under the same ownership and management.
This shared vision has led to the completion of thousands of projects, hundreds of publications, methodological advances, and a tangible and lasting impact on the healthcare landscape and the fields of epidemiology, HEOR, and market access.
Why choose Pharmerit?
We have locations in three continents allowing us to work alongside global clients from the United States and Europe to Asia.
Modeling & Meta-Analysis
Developing tools to inform policy decision-makers about the clinical and health-economic consequences of health technologies
Including the patient perspective to better understand their needs, design better studies, and assess how they value different therapies
Informing decision-making with evidence from “real-world” practice
Strategic Market Access
Communicating the evidence regarding unmet needs and the benefits and costs of treatment innovation to ensure market access and reimbursement